Bambusa Therapeutics, Inc. (BBTX) stock analysis
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.00+0.00 (0.00%)
Close on Nov 3, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Bambusa Therapeutics.
See a number that looks wrong?